Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Other Non-Current Liabilities (2016 - 2021)

Cardiff Oncology (CRDF) has disclosed Other Non-Current Liabilities for 11 consecutive years, with $5000.0 as the latest value for Q3 2021.

  • Quarterly Other Non-Current Liabilities fell 94.35% to $5000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Sep 2021, down 94.35% year-over-year, with the annual reading at $285000.0 for FY2020, 7025.0% up from the prior year.
  • Other Non-Current Liabilities hit $5000.0 in Q3 2021 for Cardiff Oncology, down from $17000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.0 million in Q3 2017 to a low of $4000.0 in Q4 2019.
  • Historically, Other Non-Current Liabilities has averaged $264289.3 across 5 years, with a median of $72701.0 in 2020.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 96.55% in 2018 and later skyrocketed 7025.0% in 2020.
  • Year by year, Other Non-Current Liabilities stood at $649387.0 in 2017, then tumbled by 95.02% to $32315.0 in 2018, then plummeted by 87.62% to $4000.0 in 2019, then surged by 7025.0% to $285000.0 in 2020, then tumbled by 98.25% to $5000.0 in 2021.
  • Business Quant data shows Other Non-Current Liabilities for CRDF at $5000.0 in Q3 2021, $17000.0 in Q2 2021, and $78000.0 in Q1 2021.